Inclusion of PF68 surfactant improves stability of rAAV titer when passed through a surgical device used in retinal gene therapy

Inclusion of PF68 surfactant improves stability of rAAV titer when passed through a surgical device used in retinal gene therapy

Recent advances in recombinant adeno-associated virus (rAAV) gene therapy for choroideremia show gene replacement to be a promising approach. It is, however, well known that contact of vector solution with plastic materials in the surgical device may result in non-specific adsorption with resulting...

Descripció completa

Dades bibliogràfiques
Autors principals:	Patrício, M, Cox, C, Blue, C, Barnard, A, Martinez-Fernandez De La Camara, C, Maclaren, R
Format:	Journal article
Idioma:	English
Publicat:	Cell Press 2019

Ítems similars

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
per: Hironori Okada, et al.
Publicat: (2013-01-01)

An amplification-free CRISPR-Cas12a assay for titer determination and composition analysis of the rAAV genome
per: Lei Yu, et al.
Publicat: (2024-09-01)

The biological activity of AAV vectors for choroideremia gene therapy can be measured by in vitro prenylation of RAB6A
per: Patrício, M, et al.
Publicat: (2018)

rAAV-mediated subcellular targeting of optogenetic tools in retinal ganglion cells in vivo.
per: Chaowen Wu, et al.
Publicat: (2013-01-01)

Crucial aspects for maintaining rAAV stability
per: Johannes Lengler, et al.
Publicat: (2024-11-01)

Polyfunctional T cells and unique cytokine clusters imprint the anti rAAV2/rAAV9 vector immune response
per: Stephan J. Holtkamp, et al.
Publicat: (2024-11-01)

Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
per: Sue Osting, et al.
Publicat: (2014-01-01)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
per: Akiko Ishii, et al.
Publicat: (2020-09-01)

CRISPR screen reveals modifiers of rAAV production including known rAAV infection genes playing an unexpected role in vector production
per: Emily E. O’Driscoll, et al.
Publicat: (2025-03-01)

Subcellular distribution of the rAAV genome depends on genome structure
per: Nuri Oh, et al.
Publicat: (2023-10-01)

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
per: Renuka Rao, et al.
Publicat: (2022-07-01)

Monobac System–A Single Baculovirus for the Production of rAAV
per: Lionel Galibert, et al.
Publicat: (2021-08-01)

rAAV1-EGFP和rAAV2-EGFP转染犬骨髓间充质干细胞的比较
Publicat: (2009-01-01)

rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing
per: Cristovão Freitas Iglesias, et al.
Publicat: (2023-02-01)

Optimization of miR-22 expression cassette for rAAV delivery on diabetes
per: Li Yang, et al.
Publicat: (2022-01-01)

Partial genome content within rAAVs impacts performance in a cell assay-dependent manner
per: Bryan Troxell, et al.
Publicat: (2023-09-01)

Unlocking DOE potential by selecting the most appropriate design for rAAV optimization
per: Konstantina Tzimou, et al.
Publicat: (2024-12-01)

An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons
per: Tatiana Tkatch, et al.
Publicat: (2022-10-01)

Proteomics analysis of co-purifying cellular proteins associated with rAAV vectors.
per: Biao Dong, et al.
Publicat: (2014-01-01)

Effects of Thermally Induced Configuration Changes on rAAV Genome’s Enzymatic Accessibility
per: Yinxia Xu, et al.
Publicat: (2020-09-01)

The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by In Vitro Prenylation of RAB6A
per: Maria I. Patrício, et al.
Publicat: (2018-06-01)

The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner
per: Adriana Gonzalez-Sandoval, et al.
Publicat: (2023-04-01)

Efficient construction of rAAV-based gene targeting vectors by Golden Gate cloning
per: Yonglun Luo, et al.
Publicat: (2014-05-01)

rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
per: Weiran Shen, et al.
Publicat: (2022-10-01)

Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
per: Kristina J. Chern, et al.
Publicat: (2022-11-01)

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
per: Artem A. Derkaev, et al.
Publicat: (2022-09-01)

Gene delivery to adipose tissue using transcriptionally targeted rAAV8 vectors.
per: Silke Uhrig-Schmidt, et al.
Publicat: (2014-01-01)

The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver
per: Chunmei Gan, et al.
Publicat: (2025-03-01)

An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases
per: Luo T, et al.
Publicat: (2022-06-01)

Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina
per: Patrício, M, et al.
Publicat: (2017)

Choroideremia: molecular mechanisms and development of AAV gene therapy
per: Patrício, M, et al.
Publicat: (2018)

Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola
per: Tan, T, et al.
Publicat: (2017)

Intramuscular rAAV2/8 mediated expression of etanercept in mice with collagen-induced arthritis
per: Habib, O, et al.
Publicat: (2019)

Identification of the role of SNARE proteins in rAAV vector production through interaction with the viral MAAP
per: Cagla Aksu Kuz, et al.
Publicat: (2025-03-01)

Temporal insights into molecular and cellular responses during rAAV production in HEK293T cells
per: Alok Tanala Patra, et al.
Publicat: (2024-09-01)

PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery
per: Liang Zou, et al.
Publicat: (2022-12-01)

Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques
per: Liam Cole, et al.
Publicat: (2021-04-01)

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19
per: Ilias B. Esmagambetov, et al.
Publicat: (2023-03-01)

Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
per: Weiran Shen, et al.
Publicat: (2023-01-01)

Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system.
per: Lionel Galibert, et al.
Publicat: (2018-01-01)